The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells

Pharmaceutical Research

Volumn 19, Issue 8, 2002, Pages 1114-1122

  David, Ayelet ^a   Kopecková, Pavla ^b   Kopeček, Jindrich ^b   Rubinstein, Abraham ^a,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF UTAH   (United States)

^c David R Bloom Center of Pharmacy   (Israel)

Author keywords

Biorecognition; Colon adenocarcinoma cells; Confocal microscopy; Galectin; HPMA copolymer; Lectin mediated drug targeting

Indexed keywords

EPITOPE; GALACTOSE; LACTOSE; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER;

ARTICLE; CANCER CELL; CELL LINE; COLON ADENOCARCINOMA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; COLONIC NEOPLASMS; GALACTOSE; HUMANS; LACTOSE; METHACRYLATES; TUMOR CELLS, CULTURED;

EID: 0036690721     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019885807067     Document Type: Article

References (30)

1. Lectins as cell recognition molecules
2. Glycobiology: Toward understanding the function of sugars
3. Endogenous lectins as targets for drug delivery
4. Receptor-mediated glycotargeting
5. Drug delivery systems using carbohydrate recognition
6. Soluble polymers for lectin-mediated drug targeting
7. Endogenous galactoside-binding lectins: A new class of functional tumor cell surface molecules related to metastasis
8. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells
9. Expression of endogenous galactose-binding lectin correlates with neoplastic progression in the colon
10. Metastasis of human colon cancer is altered by modifying expression of the β-galactoside-binding protein galectin 3
11. Involvement of galactin-3 expression in colorectal cancer progression and metastasis
12. Lactose-binding lectin expression in human colorectal carcinomas: Relation to tumor progression
13. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages
14. Characterization of membrane lectins in human colon carcinoma cells by flow cytofluorometry, drug targeting and affinity chromatography
15. Enhanced biochemical affinity of multivalent neoglycoconjugates
16. Polyvalent interactions in biologic systems: Implications for design and use of multivalent ligands and inhibitors
17. Muramyl dipeptide bound to poly-L-lysine substituted with mannose and gluconoyl residues as macrophage activators
18. Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendant galactosamine residues after intravenous administration to rats
19. HPMA copolymer-anticancer drug conjugates: Design, activity and mechanism of action
20. Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine
21. Enhanced biorecognition and internalization of HPMA copolymers containing multi- or multivalent carbohydrate side-chains by human hepatocarcinoma cells
22. Binding of synthetic oligosaccharide to the hepatic Gal/GalNAc lectin
23. Lectin-mediated drug targeting: Selection of valency, sugar type (Gal/Lac), and spacer length for distinguish ligand binding to C-type asialoglycoprotein receptor and galectins
24. Phase I clinical trial and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: First member of a new class of chemotherapeutic agents: Drug-polymer conjugates
25. Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues
26. Pharmacokinetics of a polymeric drug carrier targeted to the hepatocyte galactose receptor
27. Poly[N-(2-hydroxypropyl)methacrylamide]: Hydrodynamic properties of diluted polymer solutions
28. Targetable HPMA copolymer-adriamycin conjugates: Recognition, internalization, and subcellular fate
29. Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death